postoperative intravenous iron injections (Venofer) vs. control in total hip and knee arthroplasty
Phase 3
Completed
- Conditions
- iron defecient anemia100229581001884910043413
- Registration Number
- NL-OMON30673
- Lead Sponsor
- Atrium Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 126
Inclusion Criteria
Patients sceduled for elective total hip or knee arthroplasty with preoperative hemoglobin level above 6.8 mmol/l.
Exclusion Criteria
Patients with already threated anemia, patients with hemosiderosis, any active infection, current malignancy, uncontrolled hypertension, operated in 3 weeks before randomisation, having blood transfusions in 3 weeks before randomisation, known hypersensitivity to Venofer or one of its components.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method